Literature DB >> 9576751

Blockade of CC chemokine receptor 5 (CCR5)-tropic human immunodeficiency virus-1 replication in human lymphoid tissue by CC chemokines.

L B Margolis1, S Glushakova, J C Grivel, P M Murphy.   

Abstract

The CC chemokines MIP-1alpha, MIP-1beta, and RANTES suppress replication of certain HIV-1 strains in cultured PBMC and T cell lines by blocking interaction of gp120 with CC chemokine receptor 5 (CCR5). However, the same chemokines can enhance HIV-1 replication in cultured macrophages. The net effect of chemokines on HIV-1 infection in intact lymphoid tissue, the major reservoir of HIV-1 in vivo, is unknown and unpredictable since the tissue contains both T lymphocytes and macrophages. Here we show that exogenous MIP-1alpha, MIP-1beta, and RANTES markedly suppressed replication of CCR5-tropic HIV-1 strains in blocks of human lymphoid tissue infected ex vivo. Moreover, endogenous MIP-1alpha, MIP-1beta, and RANTES were upregulated in tissues infected ex vivo with CXC chemokine receptor 4-tropic but not CCR5-tropic HIV-1. Such an upregulation may contribute to the virus phenotype shift in the course of HIV disease in vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9576751      PMCID: PMC508773          DOI: 10.1172/JCI2015

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

Review 1.  HIV entry and tropism: the chemokine receptor connection.

Authors:  E A Berger
Journal:  AIDS       Date:  1997       Impact factor: 4.177

2.  HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor.

Authors:  Y Feng; C C Broder; P E Kennedy; E A Berger
Journal:  Science       Date:  1996-05-10       Impact factor: 47.728

3.  Infection of human tonsil histocultures: a model for HIV pathogenesis.

Authors:  S Glushakova; B Baibakov; L B Margolis; J Zimmerberg
Journal:  Nat Med       Date:  1995-12       Impact factor: 53.440

4.  Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality.

Authors:  M Tersmette; J M Lange; R E de Goede; F de Wolf; J K Eeftink-Schattenkerk; P T Schellekens; R A Coutinho; J G Huisman; J Goudsmit; F Miedema
Journal:  Lancet       Date:  1989-05-06       Impact factor: 79.321

5.  Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells.

Authors:  F Cocchi; A L DeVico; A Garzino-Demo; S K Arya; R C Gallo; P Lusso
Journal:  Science       Date:  1995-12-15       Impact factor: 47.728

6.  Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes.

Authors:  H Schmidtmayerova; H S Nottet; G Nuovo; T Raabe; C R Flanagan; L Dubrovsky; H E Gendelman; A Cerami; M Bukrinsky; B Sherry
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

7.  Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population.

Authors:  H Schuitemaker; M Koot; N A Kootstra; M W Dercksen; R E de Goede; R P van Steenwijk; J M Lange; J K Schattenkerk; F Miedema; M Tersmette
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

Review 8.  Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infection.

Authors:  G Pantaleo; C Graziosi; J F Demarest; O J Cohen; M Vaccarezza; K Gantt; C Muro-Cacho; A S Fauci
Journal:  Immunol Rev       Date:  1994-08       Impact factor: 12.988

Review 9.  Immunopathogenic mechanisms of HIV infection.

Authors:  A S Fauci; G Pantaleo; S Stanley; D Weissman
Journal:  Ann Intern Med       Date:  1996-04-01       Impact factor: 25.391

10.  Replication of HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid.

Authors:  S S Frankel; B M Wenig; A P Burke; P Mannan; L D Thompson; S L Abbondanzo; A M Nelson; M Pope; R M Steinman
Journal:  Science       Date:  1996-04-05       Impact factor: 47.728

View more
  11 in total

1.  Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo.

Authors:  S Glushakova; Y Yi; J C Grivel; A Singh; D Schols; E De Clercq; R G Collman; L Margolis
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

Review 2.  [Options in HIV therapy: present and future].

Authors:  J Röling; R Draenert; F D Goebel
Journal:  Internist (Berl)       Date:  2005-08       Impact factor: 0.743

3.  Evolution of CXCR4-using human immunodeficiency virus type 1 SF162 is associated with two unique envelope mutations.

Authors:  Yana Kiselyeva; Rebecca Nedellec; Alejandra Ramos; Cristina Pastore; Leonid B Margolis; Donald E Mosier
Journal:  J Virol       Date:  2007-01-03       Impact factor: 5.103

4.  CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue.

Authors:  M L Penn; J C Grivel; B Schramm; M A Goldsmith; L Margolis
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

5.  Nef enhances human immunodeficiency virus replication and responsiveness to interleukin-2 in human lymphoid tissue ex vivo.

Authors:  S Glushakova; J C Grivel; K Suryanarayana; P Meylan; J D Lifson; R Desrosiers; L Margolis
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

6.  Presence of host ICAM-1 in laboratory and clinical strains of human immunodeficiency virus type 1 increases virus infectivity and CD4(+)-T-cell depletion in human lymphoid tissue, a major site of replication in vivo.

Authors:  Salim Bounou; Jacques E Leclerc; Michel J Tremblay
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

7.  Hemofiltrate CC chemokine 1[9-74] causes effective internalization of CCR5 and is a potent inhibitor of R5-tropic human immunodeficiency virus type 1 strains in primary T cells and macrophages.

Authors:  Jan Münch; Ludger Ständker; Stefan Pöhlmann; Frédéric Baribaud; Armin Papkalla; Olaf Rosorius; Roland Stauber; Gabriele Sass; Nikolaus Heveker; Knut Adermann; Sylvia Escher; Enno Klüver; Robert W Doms; Wolf-Georg Forssmann; Frank Kirchhoff
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

8.  Enhancement of human immunodeficiency virus type 1 infection by the CC-chemokine RANTES is independent of the mechanism of virus-cell fusion.

Authors:  C J Gordon; M A Muesing; A E Proudfoot; C A Power; J P Moore; A Trkola
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

9.  Effective activation alleviates the replication block of CCR5-tropic HIV-1 in chimpanzee CD4+ lymphocytes.

Authors:  Julie M Decker; Kenneth P Zammit; Juliet L Easlick; Mario L Santiago; Denise Bonenberger; Beatrice H Hahn; Olaf Kutsch; Frederic Bibollet-Ruche
Journal:  Virology       Date:  2009-09-12       Impact factor: 3.616

Review 10.  Chemokines and their receptors in infectious disease.

Authors:  D H McDermott; P M Murphy
Journal:  Springer Semin Immunopathol       Date:  2000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.